The dengue-2 DNA vaccine uses the prM and E genes of a low-passage Philippine strain with E’s C-terminal transmembrane and cytoplasmic domains replaced by lysosome-associated membrane protein 1 (LAMP-1). The gene discussed is LAMP1; the disease is dengue disease.